$123.73
-0.52-0.42%
At close: -
$123.73
0.000.00%
After Hours: 1:00 PM EDT
Jazz Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Jazz Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $6.61 | $5.50 | 20.2 % |
Jun 2024 | 2024-07-31 | $5.30 | $4.80 | 10.4 % |
Mar 2024 | 2024-05-01 | $2.68 | $4.18 | -35.9 % |
Dec 2023 | 2024-02-28 | $5.02 | $5.16 | -2.71 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $1.06B | $1.04B | 1.44 % |
Jun 2024 | 2024-07-31 | $1.02B | $1.01B | 1.39 % |
Mar 2024 | 2024-05-01 | $901.98M | $953.90M | -5.44 % |
Dec 2023 | 2024-02-28 | $1.01B | $1.01B | 0.20 % |
Jazz Pharmaceuticals (JAZZ) is scheduled to report earnings on February 26, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
The Actual EPS was $6.61, which beat the estimate of $5.50.
The Actual Revenue was $1.1B, which beat the estimate of $1B.
Browse earnings estimates, EPS, and revenue on all stocks.